Partner profile: Biocompatibles shifts to Medtech 2.0 products

Following its success with drug-eluting stents and contact lenses, Biocompatibles International plc is building on its past successes by “integrating pharmaceutical and peptide therapies with new delivery technologies, including cell-based systems, for local, targeted drug delivery,” according to Donald Coppen, the company’s Partnering and Licensing Manager.
“We actually have quite a lot in our portfolio,” said Read more »